Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Reg. 34 (1) Annual Report

 46th Annual Report of Mangalam Drugs & Organics Limited for the Financial Year ended March 31, 2019. Pursuant to Regulation 34 (1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the 46th Annual Report inter-alia containing the financial statements of the Company for the year ended March 31, 2019 together with the Reports of the Board of Directors and Auditors thereon, Corporate Governance Report, Management Discussion and Analysis Report and the Notice convening 46th Annual General Meeting (AGM). 46th Annual Report for the year ended March 31, 2019 is also available on the website of the Company.
30-08-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - 46Th Annual General Meeting (AGM) Of Mangalam Drugs & Organics Limited (The Company) Scheduled To Be Held On Wednesday, September 25, 2019 At 3:30 P.M. At KILACHAND CONFERENCE ROOM, 2Nd Floor, Indian Merchants Chamber, Churchgate, Mumbai- 400020.

 Pursuant to provisions of Section 101 of the Companies Act,2013(the Act)and other applicable provisions,if any, please note that the Company has issued Notice convening the 46th AGM of the Members of the Company on Wednesday, September 25, 2019 at 3:30 P.M. at KILACHAND CONFERENCE ROOM,2nd Floor,Indian Merchants Chamber,Churchgate, Mumbai- 400020,containing businesses to be transacted thereat. Pursuant to Section 108 of the Act read with Rule 20 of the Companies(Management & Administration)Rules 2014,as amended from time to time and Regulation 44 of the SEBI Listing Regulations the Company is providing remote e-voting facility to all its Members holding shares in physical and dematerialized form as on the cut-off date of Wednesday,September 18,2019 to enable them to exercise their right to vote by electronic means on the resolutions proposed at the 46th AGM. Please find enclosed Notice convening 46th AGM of the Company for your records.
30-08-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Advertisement regarding publication of Un-Audited Financial Results for the quarter ended June 30, 2019: Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith copies of newspaper advertisement published in Free Press Journal (English daily) and Navshakti (Marathi daily), Mumbai editions, both dated July 27, 2019 in which Un-Audited Financial Results of the Company for the quarter ended June 30, 2019 have been published. The aforesaid results have been approved by the Board of Directors in its meeting held on July 26, 2019.
30-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aaditya R Dhoot & Others
26-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Un-Audited Financial Results For The Quarter Ended June 30, 2019.

 In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we are enclosing herewith Un-audited Financial Results for the quarter ended June 30, 2019 along with Limited Review Report of the said period in the prescribed form which have been taken on record and approved by the Board of Directors of the Company in its meeting held today i.e. July 26, 2019 at Mumbai. Kindly note that meeting of Board of Directors commenced at 3.00 P.M. and concluded at 4:40 P.M. Further please note that the Company has made necessary arrangement to publish the same in newspapers as required under Listing Regulations. We request you to take the same on your records.
26-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Outcome of Board Meeting

 In terms of Regulation 30 read with part A of Schedule III of the SEBI listing regulations, we have to inform you that the Board of Directors of the Company, in their meeting held today i.e. Friday, July 26, 2019 has inter-alia transacted the following business: 1. Approved the Un-Audited Financial Results for the quarter ended June 30, 2019 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; 2. Approved convening of 46th Annual General Meeting of the Company and other related matters; 3. Approved Re-appointment of Shri Govardhan M. Dhoot (DIN: 01240086) as Managing Director for next term of 5 years with effect from November 1, 2019, whose current term expires on October 31, 2019, subject to shareholders' approval being obtained in the ensuing general meeting and such other approvals, if any, required to be obtained pursuant to Companies Act, 2013 and / or the Listing Regulations. We request you to take the same on your records.
26-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aaditya R Dhoot
23-07-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Clarification

 With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Mangalam Drugs & Organics Ltd has submitted to BSE a copy of Clarification is enclosed.
22-07-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholding for the Period Ended June 30, 2019

 Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
20-07-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Clarification sought from Mangalam Drugs & Organics Ltd

 The Exchange has sought clarification from Mangalam Drugs & Organics Ltd on July 19, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
19-07-2019
Next Page
Close

Let's Open Free Demat Account